Background: Prevention of coronary heart disease (CHD) in high-risk subjects. Objective: To investigate the associations of dietary intake of alpha-linolenic acid (ALA) and linoleic acid (LA) as assessed by food frequency questionnaire and in the plasma cholesteryl ester (CE), with CHD risk factors. Design: Baseline data of a double-blind, randomized placebo-controlled trial. Subjects have hypercholesterolemia (6.0 ± 8.0 mmolal) and at least two other CHD risk factors (n 266). Results: The reported dietary ALA and LA intakes and the LAaALA ratio were associated with the contents in the CE (r 0.37, r 0.21, and r 0.42, respectively; P`0.01). In multivariate analysis, CE ALA was inversely associated with diastolic blood pressure (r 7 0.13; P`0.05) and positively with serum triacylglycerol (r 0.13; P`0.05), and CE LA was inversely associated with serum triacylglycerol (r 7 0.32; P`0.01). The CE LAaALA ratio was strongly inversely associated with CE ALA (r 7 0.95; P`0.01). In the lowest quintile of CE ALA, mean dietary intake was 0.4 energy % ALA (1.2 gaday), 8.4 energy % LA and an LAaALA ratio of 21, and in the highest quintile 0.6 energy % ALA (1.7 gaday), 6.8 energy % LA and 12 (ratio). In the lowest quintile of CE ALA the diastolic blood pressure was 4 mmHg lower (P trend`0.05), and the serum triacylglycerol 0.3 mmolal higher (P trend NS) when compared with the top quintile. Conclusions: In a CHD high-risk population with LA-rich background diet, these cross-sectional data suggest that replacing LA in the diet by ALA may decrease diastolic blood pressure, and may increase serum triacylglycerol concentration. Sponsorship: Dutch Prevent fund grant no. 28-2757; Unilever (margarine). Descriptors: alpha-linolenic acid; linoleic acid; plasma cholesteryl ester; CHD risk factors; blood pressure; serum triacylglycerol European Journal of Clinical Nutrition (2000) 54, 865±871
Introduction
The MARGARIN study is a prevention project of coronary heart disease (CHD) through a high-risk approach. The study group is composed of 266 hypercholesterolemic subjects with at least two other CHD risk factors. Our project was inspired by the Lyon Diet Heart Study. In this secondary prevention trial among patients who had a myocardial infarction, a 70% reduction in CHD events was observed in the experimental group on an alphalinolenic acid (ALA; 18 : 3n-3) rich Mediterranean diet. In the ®nal report, plasma ALA content was associated with improved prognosis (de Lorgeril et al, 1994 (de Lorgeril et al, ,1999 . Also, several large observational studies have reported on the preventive effect of dietary ALA on CHD events (Ascherio et al, 1996; Hu et al, 1999) .
ALA is the vegetary precursor of the marine long chain n-3 fatty acids eicosapentaenoic acid (EPA; 20 : 5n-3) and docosahexaenoic acid (DHA; . ALA competes with its n-6 counterpart linoleic acid (18 : 2n-6) for desaturation and chain-elongation. Linoleic acid (LA) is in this pathway converted to arachidonic acid (AA; .
In recent years, hypercholesterolemic subjects have been stimulated to decrease saturated fat intake and to consume LA-enriched food products. It is accepted that LA lowers serum lipid levels (Schaefer, 1997) . However, a steadily increasing dietary LAaALA ratio may have adverse health consequences (Renaud et al, 1995; Okuyama et al, 1997 ). An excessive amount of LA in the diet may lead to inappropriate production of n-6 eicosanoids (Lands, 1989) . One study observed a positive association between the dietary n-6an-3 ratio and cardiovascular mortality (Dolecek & Grandits, 1991) .
Accurate epidemiologic data of usual LA and ALA intake in populations are limited, mainly due to incomplete nutrient databases. Hence, in the context of the primary prevention of CHD the in¯uence of increased intake of ALA on CHD risk factors is relatively unknown (Schaefer, 1997) . Therefore, at the start of our prevention project we investigated cross-sectionally the relation between dietary ALA and LA intake and ALA and LA content of the plasma cholesteryl ester (CE) on the one hand and blood pressure, serum total and HDL cholesterol, and serum triacylglycerol on the other hand.
Subjects and methods

Study design
The MARGARIN study, abbreviated from Mediterranean alpha linolenic enriched Groningen dietary intervention study, investigates two preventive strategies: ®rst, intensive group education about Mediterranean dietary habits compared to`care as usual' for hypercholesterolemic persons (single blind); and second, supplementation of an ALAenriched margarine compared to an LA-rich margarine (double blind). The randomized placebo-controlled study design will be described in detail elsewhere (Bemelmans et al, in press ). The present study involves the baseline data, collected in November 1997. The medical ethical committee of the Groningen University Hospital approved the study design.
Study group and selection
Inclusion criteria were a mean of two serum cholesterol measurements between 6 and 8 mmolal and at least two of the following CHD risk factors: high blood pressure (diastolic ! 95 mmHg andaor systolic ! 160 mmHg) or use of anti-hypertensive medication; body mass index (BMI) ! 27 kgam 2 ; smoking; and diagnosis of cardiovascular disease, or a ®rst-degree relative with a history of cardiovascular disease prior to the age of 60 y. Exclusion criteria were age`30 or b 70 y, diabetes mellitus, hypothyroidism, and use of acetylsalicylic acid, anticoagulant or cholesterol-lowering drugs.
Potential participants with at least two CHD risk factors were invited to have their serum cholesterol measured and they were recruited in three ways. First, all inhabitants over 30 y of two municipalities received a written invitation to participate in a blood pressure screening program. Second, registration systems of three pharmacies and one family physician in these two counties were screened for patients on anti-hypertensive drugs. Third, a local radio program discussed the project and invited potential participants to contact the researchers.
Written informed consent was obtained from 282 persons. Fourteen persons dropped out prior to the baseline examinations. Two persons were further excluded because of diabetes mellitus, accidently discovered at baseline examination.
Baseline examinations
Within 2 weeks, all subjects were investigated at the regional hospital in the early morning after an overnight fast. We determined serum total cholesterol, HDL cholesterol, triacylglycerol and the plasma CE fatty acid composition. Blood pressure was measured in sitting position and bodyweight was determined without shoes and heavy clothing. Height was measured during the study in March 1998, and was assumed to be equal at baseline. A standardized questionnaire was used to provide information on smoking. CVD history and use of medication. A food frequency questionnaire was distributed 4 weeks before baseline (see below).
Samples and analysis
Serum total cholesterol, HDL-cholesterol and triacylglycerol (without blanking) were determined by enzymatic methods on a Vitros 950 (Ortho-Clinical Diagnostics, Rochester NY, USA). HDL-cholesterol was isolated by precipitation of LDL and VLDL with dextran sulfate and magnesium chloride. The CE fatty acid composition was determined with our method described previously (Hoving et al, 1988) . Brie¯y, total lipids were isolated from plasma by organic solvent extraction. The CE were isolated by solid phase extraction using an aminopropyl-silica column and converted into their methyl esters by transmethylation. The methyl esters were isolated by organic solvent extraction and injected into a gas chromatograph with¯ame ionization detection. Peak areas were recorded and converted into mola100 mol fatty acids.
Dietary assessment
Dietary intake was assessed by a self-administered semi-quantitative food frequency questionnaire, called the FFQ-ALA. The FFQ-ALA is based on two validated questionnaires, measuring total fat and fatty acids intake (Feunekes et al, 1993) , or antioxidant and macronutrient intake (Ocke et al, 1997) . We changed the composition of several product items to achieve the speci®c objectives of the MARGARIN study. The FFQ-ALA aims to accurately assess ALA and LA intake. Further, the FFQ-ALA determines the intake of total energy, fatty acids, alcohol and dietary ®bre. The intakes of energy, the macronutrients and dietary ®bre were validated with a 3 day 24 h recall method in a pilot study (n 43). Pearson correlation coef®cients (P`0.01) were as follows: energy intake (r 0.76); total fat as percentage of energy (r 0.66); saturated fatty acids (r 0.51); monounsaturated fatty acids (r 0.52); polyunsaturated fatty acids (r 0.70); alcohol (r 0.72); and ®bre in grams per day (r 0.74) (data not yet published).
The FFQ-ALA contains 165 food items, plus 12 questions about the amount of added fat, and 10 questions to determine portion sizes more accurately. The consumption frequency of each item is reported per day, week or month. Average portion sizes were assigned. The product items consist of 650 foods and the weighed item composition is based on national food consumption data (Hulshof et al, 1998) . Questionnaires were checked on completeness and unrealistic answers by the research nutritionist. Nutrient composition of the foods was obtained from the Dutch NEVO 1996-1 table (Netherlands Bureau for Nutrition Education, 1996) . Data on ALA contents were provided by a report from the National Institute of Public Health and the Environment (RIVM) (Voskuil & Feskens, 1994) , by Dutch Nevo Foundation, and by analyses performed by the department of Human Nutrition and Epidemiology of Wageningen Agricultural University (Hulshof et al, 1996) . If the ALA or LA values were not available for a food, the contents were estimated on the basis of comparable foods. The questionnaires were processed by the nutritional software package KOMEET 1 , developed by the Department of Human Nutrition and Epidemiology of Wageningen Agricultural University. Data entry was double checked.
Data evaluation and statistics
With the statistical package SPSS 6.0 (Norus Ïis, 1993) means and standard deviations were computed and nonGaussian distributed variables are also presented as medians. Differences between men and women were analyzed . Pearson correlation coef®cients were computed to test for associations between variables. For this, non-Gaussian distributed variables were transformed to their natural logarithm (dietary and CE LAaALA ratio). In multivariate analysis, partial correlation coef®cients were computed to test for independent associations of nutrient intakes with CHD risk factors.
As potential confounders with serum total cholesterol, we adjusted for age, gender, BMI, saturated fatty acids and cholesterol intake, smoking and consumption of coffee. With HDL cholesterol we adjusted for age, gender, BMI, smoking, intake of alcohol and carbohydrates. With serum triacylglycerol, we adjusted for age, gender, BMI, smoking, ®sh consumption, intake of alcohol, carbohydrates and ®bre. With blood pressure, we adjusted for age, gender, BMI, smoking, alcohol intake, ®sh consumption and antihypertensive medication.
To investigate which CE fatty acid predicted the dependent variables (CHD risk factors) independently from the other CE fatty acids, we used the regression equation described by Cambien et al (1988) . This equation controls for structural dependencies of the CE fatty acids as percentages of a composition. ANCOVA analysis provided the adjusted means of CHD risk factors for each quintile of the CE LAaALA ratio.
Results
Baseline data
In the study 266 subjects participated with at least three CHD risk factors. Mean age of the female and male participants was 55 and 53 y, respectively (Table 1) . Women had higher mean BMI than men. Mean total energy intake of men and women were 11.9 MJaday (median 11.8 MJaday) and 8.8 MJaday (median 8.4 MJaday), respectively. More women (57%) than men (37%) used anti-hypertensive medication (P`0.05). More men (61%) than women (40%) were present smokers (P`0.01).
Mean ALA and LA intake was 1.7 gaday (median 1.5 gaday) and 25.1 gaday (median 24.3 gaday), respectively, in men, and 1.2 gaday (median 1.0 gaday) and 17.8 gaday (median 15.8 gaday) in women. Mean dietary LAaALA ratio was 16.7 (median 14.4) for men, and 17.0 (median 14.7) for women. Table 2 shows the mean CE fatty acid composition. No signi®cant differences between men and women were observed. The CE LAaALA ratio was strongely inversely associated with CE ALA (r 7 0.95; P`0.01; Table 2 ).
Association of dietary intake and content of fatty acids in the cholesteryl ester Pearson correlation coef®cients of dietary ALA and LA intake (percentage of energy; en%) and the LAaALA ratio assessed by the FFQ-ALA, with corresponding compounds in the CE were 0.37, 0.21 and 0.42 (P`0.01), respectively (Table 3 ). In addition, the dietary LAaALA ratio was associated with CE AAaEPA ratio (r 0.13; P`0.05) and with the CE n-6an-3 ratio (r 0.20; P`0.01). Correlation coef®cients were similar for men and women (data not shown).
Associations of intake of alpha-linolenic and linoleic acid with confounding variables
The dietary intake of ALA was inversely associated with age (r 7 0.31; P`0.01), but the CE ALA content was not associated with age (r 7 0.08, NS). Dietary intake of ALA and CE ALA were positively associated with saturated fat intake and coffee consumption, and inversely with carbohydrate intake. The dietary intake of LA was also inversely associated with carbohydrate intake, and both dietary LA and CE LA were inversely associated with alcohol intake (Table 4) . Women n 144; differences between men and women, *P`0.05; **P`0.01. c PaS: ratio of polyunsaturatedasaturated fatty acids.
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Associations of intake of alpha-linolenic and linoleic acid with risk factors In univariate analysis, the dietary intake of ALA was positively associated with serum triacylglycerol, but in multivariate analyses neither the intake of ALA nor of LA were associated with CHD risk factors (Table 5 ). In multivariate analyses adjusted for the previous named confounders, CE ALA was positively associated with serum triacylglycerol (r 0.13; P`0.05), and inversely with diastolic blood pressure (r 7 0.13; P`0.05). The CE LA content was inversely associated with serum triacylglycerol (r 7 0.32; P`0.01) and inversely with HDL cholesterol (r 7 0.12; P`0.05). However, after adjustment for the structural interdepence of CE fatty acids with the method of Cambien et al (1988) , the inverse association between CE LA and HDL cholesterol was nonsigni®cant, while the other associations remained signi®cant.
The CE LAaALA ratio was independently inversely associated with serum triacylglycerol (r 7 0.21; P`0.05), and positively with diastolic blood pressure (r 0.13; P`0.05).
Independent associations of other fatty acids in the cholesteryl ester with risk factors
In multivariate analysis, the CE 20 : 3n-6 content was positively associated with total serum cholesterol concentration (r 0.16; P 0.01; n 248). None of the CE fatty acids were independently associated with the serum HDL cholesterol concentration. Partial correlation coef®cients between serum triacylglycerol and the fatty acids were as following: CE 14 : 0 (r 0.29), CE 16 : 0 (r 0.27) and CE 18 : 1n-7 (r 0.12) (n 252; P`0.05). None of the fatty acids were independently associated with systolic blood pressure, and CE 16 : 1n-7 was positively associated with diastolic blood pressure (r 0.13; P`0.05; n 253). The CE AAaEPA ratio and the CE n-6an-3 ratio were not signi®cantly related to blood pressure.
Dietary intake and risk factors for quintiles of fatty acid content in the cholesteryl ester
The reported intake of ALA in the lowest quintile of CE ALA was 0.4 en% (1.2 gaday) when compared with Alpha-linolenic acid and risk factors WJE Bemelmans et al 0.6 en% (1.7 gaday) in the top quintile (Table 6 ). In the lowest quintile of CE ALA the adjusted mean diastolic and systolic blood pressures were 89 and 146 mmHg, respectively, as compared to 85 mmHg (P for trend`0.05) and 143 mmHg (P for trend NS) in the top quintile. In the lowest vs the top quintile of CE ALA the adjusted mean serum triacylglycerol concentrations were 1.9 and 2.2 mmolal (P for trend NS; Table 6 ). In the lowest vs the top quintile of CE LA the adjusted mean serum triacylglycerol concentrations were 2.4 and 1.6 mmolal (P for trend`0.01). The trend of diastolic blood pressure among the CE LA quintiles was J-shaped (P for quadratic trend`0.01). The mean diastolic blood pressure in the lowest quintile was 90 mmHg, in the second quintile 83 mmHg, and in the top quintile 89 mmHg (data not shown).
Discussion
At baseline of our CHD prevention project, the hypercholesterolemic participants reported a high LA intake (mean 7.5 AE 2.8 en%). Dietary fatty acid intake is re¯ected into the CE fatty acid composition (Zock et al, 1997 ). An independent inverse association was found of plasma CE ALA and diastolic blood pressure (r 7 0.13; P`0.05), and a positive association with serum triacylglycerol concentration (r 7 0.13; P`0.05), while CE LA was inversely associated (r 7 0.32; P`0.01). In this population, according to the Framingham CHD risk function, a decrease in diastolic blood pressure of 4 mmHg, that is the difference between the lowest and top quintile of CE ALA, implies a 5% (men) to 6% (women) relative decrease in risk of developing CHD, ceteris paribus (Anderson et al, 1991) . Serum triacylglycerol is not included in this CHD risk function, but an increase of 0.3 mmolal may increase the CVD risk with 11% in men and 4.5% in women (Austin, 1999) . Therefore, the replacement of LA with ALA seems to have a net equal effect on risk of developing CHD.
It should be noted that even in the highest quintile of CE ALA the dietary LAaALA ratio (12.4) was higher than recommended. A dietary LAaALA ratio between 4.0 and 10.0 is stated as nutritional goal (Minister of National Health and Welfare, Canada, 1990; WHO and FAO Joint Consultation, 1995) . Hence, we could not compare the mean risk factors in a quintile with low ALA intake and high LAaALA ratio to a quintile with a mean LAaALA ratio in the recommended range.
Based on the correlation coef®cients with the CE fatty acid pro®le, we conclude that the FFQ-ALA reasonably estimates dietary ALA intake and LAaALA ratio, and less well estimates LA intake (r 0.21; P`0.01). The latter correlation is lower than described previously (James et al, 1993; Sarkkinen et al, 1994) , and this may be due to greater focus on ALA by compiling the FFQ-ALA. Nevertheless, since the trend in LA intake among the quintiles of CE LA was signi®cant, the FFQ-ALA may reasonably indicate LA intake as percentage of energy. A limitation of the present study was that blood pressure was measured once, while a duplo measurement may be more accurate. The absence of a signi®cant association of CE ALA with systolic blood pressure may be due to this fact. The small variance in total and HDL cholesterol level due to the inclusion criteria may have prevented a proper investigation of their associations with ALA and LA. Other studies found either a negative association between CE LA and serum total cholesterol (Moilanen et al, 1986; Sandker et al, 1993) , or no relation (De-Backer et al, 1989) . The strong inverse association of CE LA with serum triacylglycerol (r 7 0.32; P`0.01) was found previously (Moilanen et al, 1986; Cambien et al, 1988; Rosseneu et al, 1994) . However, according to dietary intake, previous research has shown that both dietary LA and ALA lowered serum triacylglycerol (Singer et al, 1990a,b) and our results also showed no independent association of dietary ALA intake with serum triacylglycerol (r 0.08; NS). An experimental study showed that replacement of LA with ALA did not in¯uence serum lipid levels (Pang et al, 1998) . Therefore, it appears unlikely that increasing ALA intake and thereby lowering the dietary LAaALA ratio would cause an increase of serum triacylglycerol level.
According to blood pressure, CE ALA was inversely associated with diastolic blood pressure (r 7 0.13; P`0.05), whereas CE LA was not associated. Previously described relations between CE LA and blood pressure were either negative , positive (Masana et al, 1996) or absent (Cambien et al, 1988; DeBacker et al, 1989) . In a study with 399 males, an increase of 1% in adipose ALA content was associated with a decrease of 5 mmHg in systolic, diastolic and mean arterial blood pressure (Berry & Hirsch, 1986) . One epidemiological study found an inverse relation between dietary ALA intake and blood pressure (Salonen et al, 1988) . Controlled experiments, with small numbers of males only, proved the hypotensive effect of the marine n-3 fatty acids to be greater than ALA (Singer et al, 1986; Kestin et al, 1990) . Nevertheless, increasing ALA intake in this population may lower blood pressure, and this hypotensive effect may be mediated through in¯uencing the dietary LAaALA ratio. Supplementation of n-3 fatty acids may lower blood pressure because of their competition with n-6 fatty acids for the enzyme cyclooxygenase (Knapp, 1991) . Endogenous synthesis of vasoactive eicosanoids may alter when the balance between n-3 and n-6 fatty acid intake is changed. Against a high LA background diet the already low conversion of ALA to EPA is further reduced (Gerster, 1998) . In the present study, dietary LAaALA ratio and CE LAaALA ratio were associated with CE AAaEPA ratio (r 0.13; P`0.05 and r 0.41; P`0.01), but CE AAaEPA ratio was not associated with blood pressure.
Hence, the competition between ALA and LA for metabolic conversion and subsequent competition for the enzyme cyclooxygenase may play a role, but other mechanisms could be involved (Singer, 1992) . In hypertensive rats increasing ALA intake was investigated against a high LA background diet. The content of ALA in the aorta rose by 12% while the concentration of EPA was unaltered. Vascular prostacyclin synthesis increased, resulting in lower blood pressure (Rupp et al, 1996) . Apparently, ALA can be converted into EPA and subsequently alters prostanoid production, without raised EPA concentration in cell membranes.
For effective CHD prevention, the impact of increased ALA intake on CHD risk factors needs to be further investigated in a prospective study design. These crosssectional results suggest that the overall net effect on CHD risk may be equal when LA in the diet is replaced with ALA. Increasing dietary ALA intake in a CHD highrisk population with an LA-rich background diet may decrease mean blood pressure, and may increase serum triacylglycerol concentration.
